CIK 0002007191 · Large accelerated filer
Telix Pharmaceuticals Ltd
Sign in to watch- Ticker
- TLPPF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Australia
- Entity type
- other
- Phone
- 61 3 9093 3855
- Business address
- 55 FLEMINGTON ROAD, NORTH MELBOURNE, Australia, 3051
Securities
- TLX American Depositary Shares Nasdaq
- TLPPF Common stock OTC
- Open-market buys, last 90 days
- $19,998
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$19,998. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-07 | Smith Darren Charlton Group Chief Financial Officer | Purchase | +2,071 | $9.66 | $20K | 13,992 |
| 2026-04-29 | Behrenbruch Christian MD & Group CEO | Purchase | +33,435 | $14.87 | $497K | 20,742,935 |
| 2026-04-28 | Behrenbruch Christian MD & Group CEO | Purchase | +34,500 | $14.48 | $500K | 20,709,500 |
| 2026-03-29 | Smith Darren Charlton Group Chief Financial Officer | Option exercise | +1,111 | 11,921 | ||
| 2026-03-29 | Smith Darren Charlton Group Chief Financial Officer | Option exercise · Share Rights | −1,111 | 0 |
Page 1 of 1 · 5 trades